Inovio Pharmaceuticals Inc banner

Inovio Pharmaceuticals Inc
F:GBM

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
F:GBM
Watchlist
Price: 0.583 EUR 4.67%
Market Cap: €40.1m

Wall St Price Targets

GBM Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast GBM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GBM is 5.972 EUR with a low forecast of 3.1 EUR and a high forecast of 10.744 EUR.

Lowest Forecast
Price Target
3.1 EUR
432% Upside
Average Forecast
Price Target
5.972 EUR
924% Upside
Highest Forecast
Price Target
10.744 EUR
1 743% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
28% Upside

Revenue
Forecast

-27% / Year
Past Growth
163% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
-27% / Year
Past Growth
163% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 8 years is 163%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GBM's stock price target?
Price Target
5.972 EUR

According to Wall Street analysts, the average 1-year price target for GBM is 5.972 EUR with a low forecast of 3.1 EUR and a high forecast of 10.744 EUR.

What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
163%

Over the last 13 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 8 years is 163%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett